Matches in Wikidata for { <http://www.wikidata.org/entity/Q66546879> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q66546879 description "clinical trial" @default.
- Q66546879 description "ensayu clínicu" @default.
- Q66546879 description "klinisch onderzoek" @default.
- Q66546879 description "клінічне випробування" @default.
- Q66546879 description "կլինիկական փորձարկում" @default.
- Q66546879 name "Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 name "Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 type Item @default.
- Q66546879 label "Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 label "Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 prefLabel "Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 prefLabel "Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 P1050 Q66546879-DE018D88-1FE4-45B5-86D7-95CC7C69D916 @default.
- Q66546879 P1132 Q66546879-728262AE-C922-4E72-8E71-41EF870AE661 @default.
- Q66546879 P1476 Q66546879-263A11F5-1FDF-4224-AAC7-223028AD3A42 @default.
- Q66546879 P17 Q66546879-0A5DE7E4-2ECF-47E9-9812-38773ABE2532 @default.
- Q66546879 P2899 Q66546879-EF3F5654-3617-4A64-953C-B245C9690132 @default.
- Q66546879 P3098 Q66546879-DD4F296C-BFE0-4AEF-9C36-66AD17B4700D @default.
- Q66546879 P31 Q66546879-93EACD4F-6BE0-40A5-8279-B86DD66179F6 @default.
- Q66546879 P4844 Q66546879-2D6F5593-BB77-42C7-A19F-3877447E2652 @default.
- Q66546879 P580 Q66546879-61ED4321-018E-4C08-8478-EC51544AC6AB @default.
- Q66546879 P582 Q66546879-A7B5A8EA-F9B4-4624-87D8-D8BAA9206E76 @default.
- Q66546879 P6099 Q66546879-7B7DD2DD-3805-44BF-B64A-FDE78795A4AE @default.
- Q66546879 P6099 Q66546879-AA327E8F-C0EC-402C-8338-18DDDD6B19B0 @default.
- Q66546879 P8363 Q66546879-06CDA017-BFEF-464B-B5CD-798B6A554B66 @default.
- Q66546879 P859 Q66546879-F541E037-E1B4-4841-A580-AF4F5262E6C9 @default.
- Q66546879 P1050 Q208414 @default.
- Q66546879 P1132 "+30" @default.
- Q66546879 P1476 "A Phase I/II Open-Label Dose-Finding Study of Ceritinib Combined With Brentuximab Vedotin for Front-Line Treatment of ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q66546879 P17 Q30 @default.
- Q66546879 P2899 "+12" @default.
- Q66546879 P3098 "NCT02729961" @default.
- Q66546879 P31 Q30612 @default.
- Q66546879 P4844 Q50429626 @default.
- Q66546879 P580 "2018-01-03T00:00:00Z" @default.
- Q66546879 P582 "2023-07-01T00:00:00Z" @default.
- Q66546879 P6099 Q42824440 @default.
- Q66546879 P6099 Q5452194 @default.
- Q66546879 P8363 Q78089383 @default.
- Q66546879 P859 Q219563 @default.